Retail sale of other food
PHARMA NORGE AS
Revenue 2024
NOK 55.2m
Operating profit
NOK 15.5m
Equity
NOK 35.5m
Incorporated
2017
Employees
27
Share capital
NOK 292,000
Roles
Daglig lederRune Meyer
Regnskapsfører
Regnskapsfører
Revisor
Styrets lederThomas Kristoffer Storvestre
Auditor
Auditor at related companies
None of the 2 related companies use the same auditor.
| Company | Auditor | |
|---|---|---|
| GLOBAL PHARMA GROUP AS | REVICOM AS | different |
| NUTRIPHARMA INTERNATIONAL AS | REVICOM AS | different |
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| GLOBAL PHARMA GROUP AS | 88.4% | 2577.000000 | 2025 |
| JAN-PETTER KROGH | 6.5% | 189.000000 | 2025 |
| PHARMA NORGE AS | 3.5% | 103.000000 | 2025 |
| INFUTURE INVEST AS | 1.6% | 46.000000 | 2025 |
Holdings in other companies
| Company | Status | Stake | Shares |
|---|---|---|---|
| NUTRIPHARMA INTERNATIONAL AS | Active | 100.0% | 750000.000000 |
| PHARMA NORGE AS | Active | 3.5% | 103.000000 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.